Summary. Background: Because they have similar functional and clinical profiles, bronchopulmonary dysplasia (BPD) survivors are often treated as asthmatic patients. In truth, very little is known about the possible biochemical and inflammatory mechanisms playing a part in BPD survivors' lungs. The aim of this study was to measure exhaled breath temperature in BPD survivors by comparison with asthmatic cases and healthy controls. Methods: Three groups of agematched adolescents (n ¼ 17 each), that is, BPD survivors (gestational ages <31 weeks, birth weights <1,500 g), asthmatic subjects and healthy controls, underwent exhaled breath temperature and exhaled nitric oxide measurements, and spirometry. Results: Exhaled breath temperature was significantly lower in the BPD survivors (26.728C [25.11-27.57]) than in the asthmatic patients (29.608C [29.20-30.02], P < 0.001), while no significant difference emerged by comparison with healthy controls (26.978C [26.58-27.38]). Considering the whole study population, a significant correlation was found between exhaled breath temperatures and exhaled nitric oxide concentrations (R ¼ 0.42, P ¼ 0.004). Spirometry revealed an obstructive lung function pattern in both the asthmatic cases and the BPD survivors, with lower parameters in the latter. Conclusions: Exhaled breath temperatures and exhaled nitric oxide concentrations are significantly lower in BPD survivors than in asthmatic cases, suggesting that different pathogenetic mechanisms characterize these two chronic obstructive lung diseases.
INTRODUCTION
Bronchopulmonary dysplasia (BPD) is the most common form of chronic lung disease of prematurity. In childhood and adolescence, BPD survivors may have respiratory symptoms and lung function impairment that closely resemble those of asthmatic patients, 1 even if BPD patients present fewer acute exacerbations, poorer response to inhaled corticosteroids and less pronounced airway reversibility. A recent study reported that low birth weight survivors have significantly higher odds of hospitalization for respiratory diseases (wheezing, respiratory infections, and respiratory failure) as young adults than their normal birth weight counterparts. 2 Although there are no data to suggest an asthma-like inflammatory profile in the airways of BPD survivors, they are often empirically treated as if they were asthmatic (e.g., with glucocorticosteroids). 3, 4 Very little is known, however, about the possible biochemical and inflammatory mechanisms involved in the pathogenesis of the symptoms and airway obstruction in BPD survivors, 3 and no data are available on the pathological features of these patients' lungs beyond infancy. 3 It is common knowledge that asthma is a chronic inflammatory disease of the airways and several noninvasive biomarkers have been proposed for indirectly assessing different patterns of airway inflammation. 5 Exhaled nitric oxide has been studied the most and it is considered a reliable marker of eosinophilic inflammation in the airways. 6, 7 Since ''calor'' is one of the cardinal signs of inflammation, some authors recently recommended considering exhaled air temperature as a potential marker of inflammation. 8, 9 Increased values of exhaled breath Silvia Carraro and Giorgio Piacentini contributed equally to this work.
temperature have been reported in children and adults with asthma, [8] [9] [10] [11] correlating significantly with the concentrations of exhaled nitric oxide. [8] [9] [10] To our knowledge, no studies have evaluated exhaled air temperature in individuals with BPD.
The aim of the present cross-sectional study was to evaluate exhaled breath temperature (PLET, endexpiratory maneuver plateau temperature) in BPD survivors and to compare it with the temperature measured in age-matched asthmatic subjects and healthy controls.
MATERIALS AND METHODS

Study Subjects
BPD Survivors
Seventeen BPD survivors were considered (Table I) , drawn from a population with BPD born at gestational ages below 31 weeks and with birth weights under 1,500 g admitted to the Neonatal Intensive Care Unit between 1990 and 1994 and followed up routinely thereafter at the Pediatrics Department in Padova. BPD was defined as oxygen dependence persisting 28 days after birth in infants on mechanical ventilation (18 days on average). At birth, the mean gestational age of the sample was 28.3 weeks (SD 1.9) and the mean weight was 1,011 g (SD 222).
All the BPD survivors were clinically stable at the time of recruitment, five of them were on low-to medium-dose inhaled steroid (ICS) treatment and two were being treated with theophylline. Two of the BPD survivors were sensitive to common airborne allergens (dust mites, dog and cat dander, grass and tree pollens).
Asthmatic Subjects
Seventeen allergic asthmatic adolescents (Table I) who had been born at term were enrolled from among those regularly attending our outpatients clinic. Their asthma had been diagnosed by a pediatric respiratory physician based on their clinical history (cough, shortness of breath, recurrent wheezing, and chest tightness) and an increase in FEV 1 after salbutamol (400 mg) >12%, according to international guidelines. 12 All the asthmatic patients were clinically stable at the time of recruitment, six of them were on low-to medium-dose inhaled steroid (ICS) treatment (100-200 mcg/day budesonide equivalent) and one of them was being treated with long-acting beta2 agonists too.
Healthy Controls
Seventeen age-matched healthy adolescents (Table I) with no history of preterm birth, atopy, or respiratory diseases were recruited as a control group.
For all three groups, subjects who had suffered any airway infections in the previous 4 weeks were excluded from the study.
The Ethics Committee of our hospital reviewed and approved the protocol and all parents gave their informed consent.
At recruitment, all the adolescents underwent physical examination, exhaled air temperature measurement, FE NO measurement, and spirometry. All the measurements were performed in the afternoon. FE NO measurement was not possible in three subjects (one with asthma and two with BPD).
Exhaled Breath Temperature (PLET)
Exhaled breath temperature (end-expiratory maneuver plateau temperature, PLET) was measured as described elsewhere. 13 The environmental conditions were controlled in order to maintain a stable temperature of 23 AE 18C and a relative humidity of 40-50%.
The measurements were repeated three times. The inspiratory air stream temperature was recorded during a complete inhalation to total lung capacity (TLC). The exhaled airway temperature was measured during a slow exhalation to residual volume (RV) using the Medical Mass Flow Sensor of the V max Spectra 229 Pulmonary Function Laboratory (VIASYS Healthcare, Yorba Linda, CA). Dynamic airway temperature and airflow were measured with the Mass Flow Sensor. The response time of the Mass Flow Sensor to a steep change in airway temperature was $64 msec, with a thermal resolution of 0.018C. Mouth pressure was measured at the airway Pediatric Pulmonology opening using a differential pressure transducer. Exhaled flow was directed through an alternate pathway with a fixed resistor in place to control the expiratory air flow rate and maintain an airway pressure sufficient to keep the velum closed and prevent any contribution of warmed gas from nasal sinuses. A mouth pressure of >5 cmH 2 O also helped the subject to stabilize the expiratory flow at 5-6 L/ min. All the signals, including exhaled air temperature, mouth pressure, and exhalation flow rate, were transferred to a personal computer and analyzed using software specifically developed for this purpose (V max temperature, VIASYS Healthcare). Real-time signal display consisted of inspiratory and expiratory airway temperature, respiratory flow rate, and mouth (airway) pressure on a time axis. Flow and pressure limit indicators were presented on screen as a coaching aid. At the end of the test, the software automatically calculated the PLET, which was the parameter used to compare the groups.
Fractional Exhaled Nitric Oxide (FE NO ) and Pulmonary Function Measurement FE NO was measured using the NIOX system (Aerocrine, Stockholm, Sweden), according to the ERS/ATS guidelines for measuring FE NO in children.
14 Children inhaled NO-free air to TLC and exhaled through a dynamic flow restrictor with a target flow of 50 ml/sec for at least 6-7 sec. No nose clip was used. The NIOX system was calibrated using a 200 ppb NO tank (Lindegas Hoek Loos Speciality Gases, Amsterdam, the Netherlands) according to the manufacturer's instructions.
Lung function was measured by means of a 10-L bell spirometer (Biomedin, Padova, Italy) and the best of three maneuvers was expressed as a percentage (%) of the predicted reference values, according to the ERS/ATS guidelines. 15 
Statistical Analysis
It has been calculated that a sample size of 17 subjects allows detecting a 18C difference between groups of with a power of 80% at a 2-sided a-level of 0.05.
Age and anthropometric data were expressed as the mean and standard deviation (SD) ( Table I) .
Since PLET, FE NO , and lung function data were not normally distributed (as demonstrated by the Shapiro-Wilk test), they were expressed as medians and interquartile ranges (IQR), and analyzed by means of non-parametric tests. Differences between groups were analyzed using the Kruskal-Wallis test, followed (where significant) by the Mann-Whitney U-test for comparisons between groups. Correlations were evaluated using Spearman's rank test. Statistical significance was set at a 2-sided a-level of 0.05.
RESULTS
Exhaled Breath Temperature (PLET)
The Kruskal-Wallis test revealed a significant difference in the PLET for the three groups (P < 0.001) (Fig. 1A) . The between-group comparison found a significantly lower PLET in BPD survivors (26.728C [25.11-27 .57]) than in asthmatic patients (29.608C [29. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] .02], P < 0.001), while no significant difference emerged between BPD survivors and healthy controls (26.978C [26.58-27 .38], P ¼ 0.23). The asthmatic cases had a significantly higher PLET than the healthy controls (P < 0.001).
Exhaled Nitric Oxide (FE NO )
The Kruskal-Wallis test found a significant difference in FE NO for the three groups (P ¼ 0.003) (Fig. 1B) 
Lung Function
The Kruskal-Wallis test disclosed significant differences in all the spirometric parameters. The betweengroup comparison showed that BPD children had lower FVC, FEV 1 , FEF , and FEV 1 /FVC than either asthmatic cases or healthy controls; and the asthmatic cases had lower FEV 1 , FEF , and FEV 1 /FVC than healthy controls (Table I and Fig. 1C,D) .
Correlations
Considering the whole sample, a significant correlation emerged between PLET and FE NO (R ¼ 0.42, P ¼ 0.004) (Fig. 2) .
In BPD survivors there was a correlation approaching statistical significance between FVC and PLET (P ¼ 0.058, R ¼ 0.47), which was stronger considering the whole sample (R ¼ 0.28, P ¼ 0.036).
None of the other spirometric parameters correlated with PLET values in BPD survivors.
No significant correlations emerged between spirometric measurements and PLET in asthmatic cases or healthy controls.
DISCUSSION
This study shows that exhaled breath temperature is significantly lower in BPD survivors than in asthmatic patients.
BPD survivors have respiratory symptoms and lung function profiles that resemble those of asthmatic children 16 and this explains why they are often considered and empirically treated as asthmatic patients during their childhood. 3 Very little it is known about the processes underlying the obstructive lung function pattern in BPD survivors and there is no evidence to support any asthmalike inflammation in this condition. 4, 17, 18 Here we demonstrate that both PLET and FE NO are lower in BPD survivors than in asthmatic children, suggesting that the two conditions have a different pathogenesis (Fig. 1A,B) . In a previous study, we already showed that exhaled NO is lower in BPD survivors than in asthmatic cases; 19 the present study further supports the lack of any asthma-like airway inflammation in BPD survivors. A possible limit in the interpretation of our results is the potential effect of ICS treatment and atopy on PLET values. In fact while all asthmatic patients were allergic, only two BPD patients were sensitized. In addition some patients in both groups were treated with ICS. In keeping with previous studies conducted on asthmatic patients, 8, 9 PLET and FE NO correlated significantly. It is worth noting that the scatter plot (Fig. 2) shows a clear separation between asthmatic cases and BPD survivors, again suggesting that different pathogenetic mechanisms underlie these two chronic obstructive lung diseases.
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As previously reported, [8] [9] [10] asthmatic subjects have higher levels of both FE NO and PLET, which are thought to reflect eosinophilic airway inflammation. 6, 20 The higher exhaled breath temperature in asthmatic subjects also seems to suggest an increased vascularity and bronchial blood flow. 10 In BPD survivors, on the other hand, PLET and FE NO are significantly lower than in asthmatic patients and even tend to be lower than in healthy controls, although without reaching the statistical significance (Fig. 1A,B) . This trend could be explained by the anatomical alterations that characterize BPD lungs, namely alveolar simplification, variable degree of interstitial fibrosis 21, 22 , and dysmorphic vascular growth. 23 These anatomical alterations might presumably be responsible for an impaired heat exchange between the bronchial vessels and the airway lumen, giving rise to normal-to-low values of exhaled air temperature in BPD survivors.
As previously reported, 24 we confirm here that BPD survivors have a lung function pattern with airflow limitation (Fig. 1C ). An autoptic study demonstrated thickening of the airway walls and an increase in smooth muscle, suggesting that these aspects may have a role in airway obstruction and hyper-responsiveness in BPD survivors. 25 Moreover, BPD survivors have a significantly reduced forced vital capacity (Fig. 1D ). This last features might be explained by the impaired growth of the BPD survivor's lungs, which would lead to reduced pulmonary volumes. Previous studies have already documented in BPD survivors an impaired lung function. 24, 26, 27 It may be that lung function impairment in BPD survivors is not just the static outcome of the initial damage, but due to an ongoing remodeling/damaging process. Although our findings go against any suggestion of an asthma-like eosinophilic inflammatory profile, other inflammatory pathways (e.g., neutrophilic or lymphocytic) and/or remodeling mechanisms may be involved. Elucidating this pathophysiological substrate could have an impact on the long-term management of BPD subjects.
In conclusion, we showed that exhaled breath temperature (PLET) and exhaled nitric oxide (which are considered biomarkers of airway inflammation) are not increased in BPD survivors. Further studies are needed to assess the role of other non-invasive biomarkers, as measured for instance in exhaled breath condensate, to shed light on the pathogenic processes affecting the BPD survivor's lung and thus pave the way to the development of new, specifically targeted drugs.
